Research Article
[Retracted] Surgical Strategy and Prognosis of Pancreatic Neuroendocrine Tumors Based on Smart Medical Imaging
Table 5
Analysis of factors related to survival of pNET patients.
| Factor | Number | Survival rate (%) | P |
| Gender | Male | 10 | 83.8 | 0.976 | Female | 18 | 91.8 |
| Age | <50 | 12 | 100 | 0.139 | >50 | 16 | 81.3 |
| Is it functional | Yes | 8 | 100 | 0.268 | No | 20 | 85.0 |
| Is there distant metastasis before operation | Yes | 4 | 25 | 0.000 | No | 24 | 100 |
| Chemotherapy or not | Yes | 2 | 100 | 0.611 | No | 26 | 88.5 |
| Tumor diameter (CM) | ≦1.5 | 4 | 100 | 0.338 | 1.5∼5 | 16 | 93.8 | >5 | 8 | 75.0 |
| TNM staging | IA | 11 | 100 | 0.002 | IB | 8 | 100 | IIA | 1 | 100 | IIB | 3 | 100 | III | 2 | 50 | IV | 3 | 33.3 |
| WHO staging | G1 | 18 | 100 | 0.002 | G2 | 7 | 85.7 | G3 | 3 | 33.3 |
| Lymph node metastasis | Yes | 5 | 89.3 | 0.022 | No | 23 | 95.7 |
| Operation mode | RO | 25 | 95.5 | 0.018 | Appease | 3 | 33.3 |
|
|